Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.1300 (-3.02%) ($5.1300 - $5.1300) on Wed. Jun. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.73% (three month average) | RSI | 66 | Latest Price | $5.1300(-3.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 8.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(5%) SLV(-12%) SDY(90%) REMX(-30%) XLU(38%) | Factors Impacting CAPR price | CAPR will decline at least -2.365% in a week (0% probabilities). IWO(28%) JETS(-7%) IWM(30%) IWN(33%) GDXJ(26%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.365% (StdDev 4.73%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.41(-5.18%) | 10 Day Moving Average | $5.38(-4.65%) | 20 Day Moving Average | $4.89(4.91%) | To recent high | -10.2% | To recent low | 0.9% | Market Cap | $101m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |